(Q28217381)

7

0 references

Michelle M Le Beau

6

object named as

Michelle M Le Beau

0 references

author name string

Marianne Greene

2

0 references

Michael A McDevitt

3

0 references

John Anastasi

4

0 references

Judith E Karp

The management of neoplastic disorders of haematopoiesis in children with Down's syndrome

5

0 references

language of work or name

English

0 references

publication date

September 2002

0 references

published in

Nature Genetics

0 references

volume

32

0 references

issue

1

0 references

page(s)

148-52

0 references

cites work

1 reference

7 January 2021

Localization of the chromosome 22 breakpoints in two cases of acute megakaryoblastic leukemia with t(1;22)(p13;q13)

1 reference

7 January 2021

Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia.

1 reference

7 January 2021

FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation

1 reference

7 January 2021

The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line.

1 reference

7 January 2021

Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line

1 reference

7 January 2021

In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis

1 reference

7 January 2021

Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1

1 reference

7 January 2021

Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation

1 reference

7 January 2021

X-linked thrombocytopenia caused by a novel mutation of GATA-1

1 reference

7 January 2021

Diversification of haematopoietic stem cells to specific lineages.

1 reference

7 January 2021

A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development

1 reference

7 January 2021

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

1 reference

7 January 2021

In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis

1 reference

7 January 2021

Use of altered specificity mutants to probe a specific protein-protein interaction in differentiation: the GATA-1:FOG complex

1 reference

7 January 2021

Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor

1 reference

7 January 2021

Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia

1 reference

7 January 2021

Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1.

1 reference

7 January 2021

Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1

1 reference

7 January 2021

A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1.

1 reference

7 January 2021

Comprehensive genotypic analysis of leukemia: clinical and therapeutic implications

1 reference

7 January 2021

Chromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukemia

1 reference

7 January 2021

Amplification of AML1 in childhood acute lymphoblastic leukemias

1 reference

7 January 2021

dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53

1 reference

7 January 2021

A palindromic regulatory site within vertebrate GATA-1 promoters requires both zinc fingers of the GATA-1 DNA-binding domain for high-affinity interaction

1 reference

7 January 2021